 |
Latest Clinical Trial News
France cuts clinical trial fees
Researchers in France no longer have to pay fees to register clinical trials with Afssaps, the national medicines regulator.
Tuesday 6 January 2009
Serbia to participate in Phase III NSCLC vaccine trial
Monday 5 January 2009
US says more data needed for Salix's colitis drug
Monday 5 January 2009
Newron starts late-stage ralfinamide trial in back pain
Tuesday 30 December 2008
FDAAA trial registration requirements clarified
Tuesday 30 December 2008
Glenmark expects early launch of Napo's crofelemer
Monday 29 December 2008
Dynavax ends hepatitis B vaccine partnership with Merck
Dynavax Technologies has ended a global licence and development agreement with Merck & Co...
Tuesday 23 December 2008
AstraZeneca pays MAP a potential $900 million for budesonide
AstraZeneca is to pay up to $900 million to co-develop and commercialise Map Pharmaceuticals' unit dose budesonide (UDB).
Tuesday 23 December 2008
New data bode well for eculizumab in Japan
Thursday 18 December 2008
Progress for OncoTherapy's lead cancer vaccine
Thursday 18 December 2008
About Scrip
Scrip World Pharmaceutical News provides you with high quality news coverage of pharma and biotech and also gives you strategic data and analysis.
Benefits include:
›› Daily email headlines
›› Searchable news
archive
›› Weekly copies of Scrip
›› Bespoke Scrip supplements
›› Plus the Scrip Yearbook
and Scrip League Tables
Scrip Awards 2008
The best and brightest of the pharmaceutical and biotech industries were celebrated at a glittering ceremony in London at the 2008 Scrip Awards.
Read the full story
Scrip Directory
Scrip Directory 2008
Search over 20,000 international contacts and access potential business opportunities
© Informa plc. All rights reserved. This site is owned and operated by Informa plc ("Informa") whose registered office is
Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
